| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| WAMLOX 10 mg/160 mg | COMBINATII (AMLODIPINUM+VALSARTANUM) | COMPR. FILM. | C09DB01 | W63243009 | KRKA, D.D., NOVO MESTO - SLOVENIA | ||||||
| WAMLOX 10 mg/160 mg | COMBINATII (AMLODIPINUM+VALSARTANUM) | COMPR. FILM. | C09DB01 | W63243008 | KRKA, D.D., NOVO MESTO - SLOVENIA | ||||||
| WAMLOX 10 mg/160 mg | COMBINATII (AMLODIPINUM+VALSARTANUM) | COMPR. FILM. | C09DB01 | W63243007 | KRKA, D.D., NOVO MESTO - SLOVENIA | ||||||
| WAMLOX 10 mg/160 mg | COMBINATII (AMLODIPINUM+VALSARTANUM) | COMPR. FILM. | C09DB01 | W63243006 | KRKA, D.D., NOVO MESTO - SLOVENIA | ||||||
| WAMLOX 10 mg/160 mg | COMBINATII (AMLODIPINUM+VALSARTANUM) | COMPR. FILM. | C09DB01 | W63243005 | KRKA, D.D., NOVO MESTO - SLOVENIA | ||||||
| WAMLOX 10 mg/160 mg | COMBINATII (AMLODIPINUM+VALSARTANUM) | COMPR. FILM. | C09DB01 | W63243004 | KRKA, D.D., NOVO MESTO - SLOVENIA | ||||||
| WAMLOX 10 mg/160 mg | COMBINATII (AMLODIPINUM+VALSARTANUM) | COMPR. FILM. | C09DB01 | W63243003 | KRKA, D.D., NOVO MESTO - SLOVENIA | ||||||
| WAMLOX 10 mg/160 mg | COMBINATII (AMLODIPINUM+VALSARTANUM) | COMPR. FILM. | C09DB01 | W63243002 | KRKA, D.D., NOVO MESTO - SLOVENIA | ||||||
| WAMLOX 10 mg/160 mg | COMBINATII (AMLODIPINUM+VALSARTANUM) | COMPR. FILM. | C09DB01 | W63243001 | KRKA, D.D., NOVO MESTO - SLOVENIA | ||||||
| WAKIX 4,5 mg | PITOLISANTUM | COMPR. FILM. | N07XX11 | W64492001 | BIOPROJET PHARMA - FRANTA | X | |||||
| WAKIX 18 mg | PITOLISANTUM | COMPR. FILM. | N07XX11 | W64493001 | BIOPROJET PHARMA - FRANTA | X | |||||
| VYXEOS LIPOSOMAL 44 mg/100 mg | COMBINATII (DAUNORUBICINUM+CYTARABINUM) | PULB. PT. CONC. PT. SOL. PERF. | L01XY01 | W69088001 | ALLIANCE HEALTHCARE ROMANIA S.R.L. - ROMANIA | X | |||||
| VYXEOS LIPOSOMAL 44 mg/100 mg | COMBINATII (DAUNORUBICINUM+CYTARABINUM) | PULB. PT. CONC. PT. SOL. PERF. | L01XY01 | W68462003 | JAZZ PHARMACEUTICALS IRELAND LTD. - IRLANDA | X | |||||
| VYXEOS LIPOSOMAL 44 mg/100 mg | COMBINATII (DAUNORUBICINUM+CYTARABINUM) | PULB. PT. CONC. PT. SOL. PERF. | L01XY01 | W68462002 | JAZZ PHARMACEUTICALS IRELAND LTD. - IRLANDA | X | |||||
| VYXEOS LIPOSOMAL 44 mg/100 mg | COMBINATII (DAUNORUBICINUM+CYTARABINUM) | PULB. PT. CONC. PT. SOL. PERF. | L01XY01 | W68462001 | JAZZ PHARMACEUTICALS IRELAND LTD. - IRLANDA | X | |||||
| VYVGART 1000 mg | EFGARTIGIMODUM ALFA | SOL. INJ. | L04AA58 | W70214001 | ARGENX BV - BELGIA | X | |||||
| VYVGART | EFGARTIGIMODUM ALFA | CONC. PT. SOL. PERF. | L04AA58 | W69156001 | ARGENX BV - BELGIA | X | |||||
| VYNDAQEL | TAFAMIDIS | CAPS. MOI | N07XX08 | W66576001 | PFIZER EUROPE MA EEIG - BELGIA | X | |||||
| VYNDAQEL | TAFAMIDIS | CAPS. MOI | N07XX08 | W64784003 | PFIZER EUROPE MA EEIG - BELGIA | X | |||||
| VYNDAQEL | TAFAMIDIS | CAPS. MOI | N07XX08 | W64784002 | PFIZER EUROPE MA EEIG - BELGIA | X |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman